fondaparinux
Drug Name | Form | Strength | ARHS | Blue Ridge | Caldwell | Chatham | Johnston | Lenoir | Medical Center | Nash | Pardee | Rex | Rockingham | Southeastern | Wayne | Youth Behavioral Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fondaparinux | SOLUTION, SUBCUTANEOUS | 5 mg/mL (0.5 mL) | ||||||||||||||
Fondaparinux | SOLUTION, SUBCUTANEOUS | 12.5 mg/mL (0.8 mL) | ||||||||||||||
Fondaparinux | SOLUTION, SUBCUTANEOUS | 12.5 mg/mL (0.4 mL) | ||||||||||||||
Fondaparinux | SOLUTION, SUBCUTANEOUS | 12.5 mg/mL (0.6 mL) |
UNC Health
Management of Heparin-Induced Thrombocytopenia Guideline
Caldwell
Emergent Anticoagulation Reversal Guideline
Johnston
Anticoagulation Management Policy
Lenoir
Anticoagulation Reversal Guideline
Pardee
Anticoagulation and Thrombolytic Monitoring Procedure
Rex
Cardiology Renal Dose Adjustment Policy